Oxurion NV (OXUR.BR)
EUR 0.27
(0.0%)
EUR 0.27
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 128 Thousand EUR | 2460.0% |
| 2022 | 5000.00 EUR | -91.67% |
| 2021 | 60 Thousand EUR | -29.41% |
| 2020 | 85 Thousand EUR | 325.0% |
| 2019 | 20 Thousand EUR | -98.07% |
| 2018 | 1.03 Million EUR | -52.99% |
| 2017 | 2.2 Million EUR | -15.68% |
| 2016 | 2.61 Million EUR | -59.77% |
| 2015 | 6.49 Million EUR | -10.05% |
| 2014 | 7.22 Million EUR | 18.21% |
| 2013 | 6.11 Million EUR | 0.0% |
| 2012 | - EUR | 0.0% |
| 2011 | - EUR | 0.0% |
| 2010 | - EUR | 0.0% |
| 2009 | - EUR | 0.0% |
| 2008 | - EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - EUR | 0.0% |
| 2023 FY | 128 Thousand EUR | 2460.0% |
| 2023 Q4 | 373.00 EUR | 0.0% |
| 2023 Q2 | 1.00 EUR | 0.0% |
| 2022 Q4 | 5000.00 EUR | 0.0% |
| 2022 Q2 | 51 Thousand EUR | 0.0% |
| 2022 FY | 5000.00 EUR | -91.67% |
| 2021 FY | 60 Thousand EUR | -29.41% |
| 2021 Q2 | 85 Thousand EUR | 0.0% |
| 2021 Q4 | 60 Thousand EUR | 0.0% |
| 2020 Q4 | 85 Thousand EUR | 0.0% |
| 2020 Q2 | 20 Thousand EUR | 0.0% |
| 2020 FY | 85 Thousand EUR | 325.0% |
| 2019 Q2 | 413 Thousand EUR | 0.0% |
| 2019 FY | 20 Thousand EUR | -98.07% |
| 2019 Q4 | 20 Thousand EUR | 0.0% |
| 2018 Q4 | 1.03 Million EUR | 0.0% |
| 2018 FY | 1.03 Million EUR | -52.99% |
| 2018 Q2 | 2.14 Million EUR | 0.0% |
| 2017 Q2 | 2.29 Million EUR | 0.0% |
| 2017 FY | 2.2 Million EUR | -15.68% |
| 2017 Q4 | 2.2 Million EUR | 0.0% |
| 2016 FY | 2.61 Million EUR | -59.77% |
| 2016 Q4 | 2.61 Million EUR | 0.0% |
| 2016 Q2 | 6.26 Million EUR | 0.0% |
| 2015 Q2 | 7.15 Million EUR | 0.0% |
| 2015 FY | 6.49 Million EUR | -10.05% |
| 2015 Q4 | 6.49 Million EUR | 0.0% |
| 2014 Q2 | 8.49 Million EUR | 0.0% |
| 2014 FY | 7.22 Million EUR | 18.21% |
| 2014 Q4 | 7.22 Million EUR | 0.0% |
| 2013 Q2 | 2.46 Million EUR | 0.0% |
| 2013 FY | 6.11 Million EUR | 0.0% |
| 2013 Q4 | 6.11 Million EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 FY | - EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| 2010 Q4 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 FY | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2008 FY | - EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | 42.081% |
| ABIVAX Société Anonyme | 1.00 EUR | -12799900.0% |
| Adocia SA | 272 Thousand EUR | 52.941% |
| Aelis Farma SA | 53 Thousand EUR | -141.509% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 92.648% |
| genOway Société anonyme | 982.75 Thousand EUR | 86.975% |
| IntegraGen SA | 311.44 Thousand EUR | 58.902% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | 22.246% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 111.546% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 89.547% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 207.404% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | -40.659% |
| Valbiotis SA | 1 Million EUR | 87.264% |
| TheraVet SA | 123.34 Thousand EUR | -3.776% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -12799900.0% |
| argenx SE | 281.12 Million EUR | 99.954% |
| BioSenic S.A. | - EUR | -Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 89.841% |
| DBV Technologies S.A. | 1.00 USD | -12799900.0% |
| Galapagos NV | 73.97 Million EUR | 99.827% |
| Genfit S.A. | 4000.00 EUR | -3100.0% |
| GeNeuro SA | - EUR | -Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | -12799900.0% |
| Innate Pharma S.A. | 1.00 EUR | -12799900.0% |
| Inventiva S.A. | 417 Thousand EUR | 69.305% |
| MaaT Pharma SA | 190 Thousand EUR | 32.632% |
| MedinCell S.A. | -6.71 Million EUR | 101.906% |
| Nanobiotix S.A. | 200 Thousand EUR | 36.0% |
| Onward Medical N.V. | 936 Thousand EUR | 86.325% |
| Oryzon Genomics S.A. | 6029.00 EUR | -2023.072% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Pharming Group N.V. | 51.38 Million EUR | 99.751% |
| Poxel S.A. | 2.95 Million EUR | 95.67% |
| GenSight Biologics S.A. | 1.00 EUR | -12799900.0% |
| Transgene SA | - EUR | -Infinity% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 1.03 Billion EUR | 99.988% |
| Valneva SE | 44.46 Million EUR | 99.712% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -12799900.0% |